StockData
Zomedica Corp. logo

Zomedica Corp. (ZOMDF) stock

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica net income

Net income is the profit left for shareholders after every expense, interest and tax.

Zomedica's net income for the twelve months ending Jun 30, 2026 was -$18.95M. For fiscal 2025 it was -$81.86M. The highest annual figure on record is -$5.74M in fiscal 2016.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$81.86M–
FY2024Dec 31, 2024-$46.98M–
FY2023Dec 31, 2023-$34.53M–
FY2022Dec 31, 2022-$17.02M–
FY2021Dec 31, 2021-$18.38M–
FY2020Dec 31, 2020-$16.91M–
FY2019Dec 31, 2019-$19.78M–
FY2018Dec 31, 2018-$16.65M–
FY2017Dec 31, 2017-$8.07M–
FY2016Dec 31, 2016-$5.74M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.77M–
Q1 FY2026Mar 31, 2026-$4.53M–
Q4 FY2025Dec 31, 2025-$4.53M–
Q3 FY2025Sep 30, 2025-$6.12M–
Q2 FY2025Jun 30, 2025-$7.40M–
Q1 FY2025Mar 31, 2025-$63.81M–
Q4 FY2024Dec 31, 2024-$7.19M–
Q3 FY2024Sep 30, 2024-$6.70M–
Q2 FY2024Jun 30, 2024-$23.93M–
Q1 FY2024Mar 31, 2024-$9.16M–
Q4 FY2023Dec 31, 2023-$22.41M–
Q3 FY2023Sep 30, 2023-$491.00K–
Q2 FY2023Jun 30, 2023-$5.25M–
Q1 FY2023Mar 31, 2023-$6.39M–
Q4 FY2022Dec 31, 2022-$2.81M–
Q3 FY2022Sep 30, 2022-$5.00M–
Q2 FY2022Jun 30, 2022-$5.27M–
Q1 FY2022Mar 31, 2022-$3.94M–
Q4 FY2021Dec 31, 2021-$3.29M–
Q3 FY2021Sep 30, 2021-$6.35M–
Q2 FY2021Jun 30, 2021-$4.71M–
Q1 FY2021Mar 31, 2021-$4.04M–
Q4 FY2020Dec 31, 2020-$4.17M–
Q3 FY2020Sep 30, 2020-$4.98M–
Q2 FY2020Jun 30, 2020-$5.31M–
Q1 FY2020Mar 31, 2020-$2.45M–
Q4 FY2019Dec 31, 2019-$2.86M–
Q3 FY2019Sep 30, 2019-$2.85M–
Q2 FY2019Jun 30, 2019-$2.40M–
Q1 FY2019Mar 31, 2019-$11.68M–
Q4 FY2018Dec 31, 2018-$8.42M–
Q3 FY2018Sep 30, 2018-$1.91M–
Q2 FY2018Jun 30, 2018-$4.14M–
Q1 FY2018Mar 31, 2018-$2.17M–
Q4 FY2017Dec 31, 2017-$2.56M–
Q3 FY2017Sep 30, 2017-$2.08M–
Q2 FY2017Jun 30, 2017-$1.59M–
Q1 FY2017Mar 31, 2017-$1.83M–

More Zomedica figures

See a number that looks wrong?